San Francisco, CA, USA., February 23, 2016 – TRIANNI, Inc. (“Trianni”), a biotechnology company with proprietary antibody discovery technology, announced today it will be a Conference Supporter for the 13th Annual BIO Asia International Conference held March 15-16, 2016 in Tokyo, Japan.
On Tuesday, March 15, TRIANNI will present an overview of their technology and service offerings. Speaker will be Zishan Haroon, M.D., Ph.D., Chief Business Officer of TRIANNI. He has with extensive experience in drug discovery and development over the last two decades. In addition, he has managed business and corporate functions in both Venture and Private Equity for the last 15 years.
“TRIANNI is delighted to sponsor BioAsia for the first time ever. We are looking forward to meeting other businesses eager to utilize monoclonal antibody therapies in their R&D efforts” – stated Dr. Z.
About Trianni, Inc.
Trianni is a privately held organization, formed in 2010 with a mission to enterprise recent advances in DNA synthesis and genomic modification technology for the development of an optimized therapeutic antibody discovery platform, The Trianni Mouse. The company has research and administrative facilities in the San Francisco Bay Area (CA, USA) and in Research Triangle Park (NC, USA). For more information, please visit www.trianni.com.
Zishan Haroon, MD, PhD
Chief Business Officer
Director of Marketing